Trial NCT04151563

View at ClinicalTrials.gov 
Org. Study IDs: CA209-79X
Secondary IDs: 2018-004283-65

Last trial update was posted on 2023-12-19

MeSH Interventions

Docetaxel Ipilimumab Nivolumab Ramucirumab

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Carcinoma, Non-small Cell Lung Cancer

Stopping Reasons

Business objectives have changed

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID